Bernard Stulberg, MD


Bernard Stulberg, MD

Appointed: 1980

Bernard Stulberg, MD
Department: Orthopaedic Surgery
Location: Lutheran Hospital
Mail Code Luth
1730 W. 25th Street
Cleveland, OH 44113
Bernard Stulberg, MD
Department: Orthopaedic Surgery
Location: Hillcrest Hospital
Mail Code Luth
6770 Mayfield Road
Mayfield Heights, OH 44124
Adults Only

Biographical Sketch

Professor of Surgery, Orthopaedic Surgery, Lerner College of Medicine of CWRU; acknowledged expertise in primary and revision hip and knee replacement surgery and materials as related to orthopaedic devices. Authority on Avascular necrosis of the hip. Publishes and speaks widely regarding topics in the above areas.

Professional Highlights

  • Senior member of the Hip Society, Knee Society, and American Association of Hip and Knee Surgeons
  • Former Chairman of the Bioengineering Committee and The Orthopaedic Device Forum of the American Academy of Orthopaedic Surgeons
  • Past President of the Mid America Orthopaedic Association; President Elect of the Hospital for Special Surgery Alumni Association

Education & Fellowships

Fellowship - Weill Cornell Medical, Hospital for Special Surgery
Research Fellow Orthopaedic Surgery
New York, NY USA
Fellowship - Memorial Sloan-Kettering Cancer Center
Orthopaedic Surgery Service
New York, NY USA
Residency - Weill Cornell Medical, Hospital for Special Surgery
Orthopaedic Surgery
New York, NY USA
Residency - University of Chicago Hospitals
General Surgery
Chicago, IL USA
Internship - University of Chicago Hospitals
General Surgery
Chicago, IL USA
Medical School - University of Michigan Medical School
Ann Arbor, MI USA
Undergraduate - University of Michigan
Political Science
Ann Arbor, MI USA


  • Orthopaedic Surgery

Specialty Interests

Primary and revision total knee arthroplasty, primary and revision total hip arthroplasty, avascular necrosis, resurfacing total hip arthroplasty, surgical navigation

Innovations & Patents

  • Microloc Total Knee
  • Continuuum Total Knee System
  • Optetrack CR Slope TKA and concept for cruciate retaining TKA


  • Hip Society; Knee Society
  • American Association of Hip and Knee Surgeons

Treatment & Services

  • Arthritis Surgery
  • Arthroplasty
  • Complex Primary Hip Arthroplasty
  • Complex Primary Knee Arthroplasty
  • Hip & Knee Surgery
  • Hip Osteotomy
  • Hip Replacement
  • Hip Revision
  • Joint Aspiration
  • Joint Reconstruction
  • Joint Replacement
  • Joint Replacement Of The Knee
  • Knee Osteotomy
  • Knee Revision
  • Knee Surgery
  • Minimally Invasive Surgery
  • Primary And Revision Joint Replacements
  • Primary And Revision Total Hip Arthroplasty
  • Primary And Revision Total Knee Arthroplasty
  • Reconstructive Surgery Of The Hip
  • Reconstructive Surgery Of The Knee
  • Resurfacing Total Hip Arthroplasty
  • Revision Hip Arthroplasty
  • Revision Hip Joint Replacement
  • Revision Joint Replacement
  • Revision Knee Arthroplasty
  • Revision Knee Joint Replacement
  • Revision Total Hip Replacement
  • Revision Total Knee Replacement
  • Surgery
  • Surgical Treatment Of Arthritis Of The Hips And Knees
  • Therapeutic Injections
  • Total Hip And Total Knee Replacement
  • Total Joint Replacement
  • Total Knee Replacement
  • Viscosupplementation

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/24/2012, Dr. Stulberg has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Stulberg received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Exactech, Inc.
  • Medtronic, Inc.
  • Stryker Corporation

Royalty Payments. Dr. Stulberg receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • Exactech, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site